Turning perfusion into repair through ferroptosis blockade

Area of Science:

• Organ transplantation
• Cellular injury mechanisms
• Pharmacology

Background:

• Graft dysfunction remains a significant challenge in organ transplantation.
• Ferroptosis, a form of regulated cell death, has emerged as a key contributor to graft injury.
• Machine perfusion is increasingly used for organ preservation, but its potential for therapeutic intervention is underexplored.

Purpose of the Study:

• To investigate graft ferroptosis as a targetable vulnerability.
• To evaluate the efficacy of FXT-001 in mitigating lipid-radical injury during machine perfusion.
• To assess the impact of FXT-001 treatment on liver and lung graft function.

Main Methods:

• Identification of ferroptosis as a critical pathway in graft injury during machine perfusion.
• Administration of FXT-001, a novel therapeutic agent, during the machine perfusion of liver and lung grafts.
• Assessment of graft function and viability through various biochemical and histological analyses.

Main Results:

• Veeckmans et al. identified graft ferroptosis as a druggable vulnerability.
• FXT-001 effectively intercepted lipid-radical injury during machine perfusion.
• Treatment with FXT-001 led to improved function in both liver and lung grafts.

Conclusions:

• Ferroptosis represents a key therapeutic target to enhance graft viability.
• Machine perfusion can serve as a window for preimplantation graft repair using agents like FXT-001.
• Further postimplantation studies are required to validate the long-term benefits of this approach.